Filing Details
- Accession Number:
- 0001140361-13-041823
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-11-12 16:31:40
- Reporting Period:
- 2013-11-07
- Filing Date:
- 2013-11-12
- Accepted Time:
- 2013-11-12 16:31:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1030206 | Vascular Solutions Inc | VASC | Surgical & Medical Instruments & Apparatus (3841) | 411859679 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1213867 | L John Erb | C/O Vascular Solutions Inc 6464 Sycamore Court N. Minneapolis MN 55369 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-11-07 | 10,000 | $10.89 | 17,985 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-11-07 | 10,000 | $19.38 | 7,985 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-11-07 | 10,000 | $9.88 | 17,985 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-11-07 | 10,000 | $19.37 | 7,985 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-11-08 | 10,000 | $7.88 | 17,985 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-11-08 | 10,000 | $19.64 | 7,985 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-11-08 | 10,000 | $9.41 | 17,985 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-11-08 | 10,000 | $6.36 | 27,985 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-11-08 | 20,000 | $19.41 | 7,985 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-11-07 | 10,000 | $0.00 | 10,000 | $10.89 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-11-07 | 10,000 | $0.00 | 10,000 | $9.88 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-11-08 | 10,000 | $0.00 | 10,000 | $7.88 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-11-08 | 10,000 | $0.00 | 10,000 | $9.41 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-11-08 | 10,000 | $0.00 | 10,000 | $6.36 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2014-04-22 | No | 4 | M | Direct | |
| 0 | 2015-04-19 | No | 4 | M | Direct | |
| 0 | 2016-04-18 | No | 4 | M | Direct | |
| 0 | 2017-04-24 | No | 4 | M | Direct | |
| 0 | 2018-04-22 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 7,985 | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | $6.39 | 2019-04-21 | 10,000 | 10,000 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $9.61 | 2020-04-22 | 10,000 | 10,000 | Direct | |
| Common Stock | Stock Option (Right to Buy) | $11.72 | 2021-04-22 | 20,000 | 20,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2019-04-21 | 10,000 | 10,000 | Direct |
| 2020-04-22 | 10,000 | 10,000 | Direct |
| 2021-04-22 | 20,000 | 20,000 | Direct |
Footnotes
- The price in column 4 is a weighted average price. The prices actually received for the stock ranged from $19.18 to $19.45 per share. Mr. Erb has provided to the Company and, upon request, will provide any security holder of the Company or the SEC staff information regarding the number of shares sold at each price within that range.
- The price in column 4 is a weighted average price. The prices actually received for the stock ranged from $19.37 to $19.40 per share. Mr. Erb has provided to the Company and, upon request, will provide any security holder of the Company or the SEC staff information regarding the number of shares sold at each price within that range.
- The price in column 4 is a weighted average price. The prices actually received for the stock ranged from $19.38 to $19.80 per share. Mr. Erb has provided to the Company and, upon request, will provide any security holder of the Company or the SEC staff information regarding the number of shares sold at each price within that range.
- The price in column 4 is a weighted average price. The prices actually received for the stock ranged from $19.25 to $19.73 per share. Mr. Erb has provided to the Company and, upon request, will provide any security holder of the Company or the SEC staff information regarding the number of shares sold at each price within that range.
- 100% fully vested.
- Vests over 4 years at a rate of 4% on May 22, 2011 and 2% on the 22nd day of each succeeding month; subject to continuation of service as a Director of the Company.
Billionaire Hedge Funds
